IQ Products - Cancer Research Antibodies

IQ Products offers more than 275 antibodies antibodies against several biomarkers with a focus for the research in cervical cancer, ovarian cancer, breast cancer and and uterine/endometrial

Insight in biomarkers that play a role in the etiology of cancer might lead to better diagnostic methods for the (early) detection of cancer. More importantly, biomarkers that can correctly predict outcomes would play a major role in clinical decision making. Read more

View supplier page

Special features

Analysis of tumor (stem) cells
Cervical cancer biomarkers
Ovarian cancer biomarkers
For Research Use Only [RUO]

Applications

Immunohistochemistry
Immunocytochemistry
ELISA
Flow Cytometry
Western Blot

Featured Biomarkers for...

Cervical & ovarian cancer

CDKN2a (P16INK4A)

Ovarian cancer

Cervical cancer

Find your cancer research antibodies

IQ Products women health cancer research antibodies

ABCG2 (1H2)	CDKN1B	FOXP1	MSH6 (3E1)	PMS2 (6A12H9)
ABCG2 (3G8)	CDKN1C	FoxP3	MSH6 (5B11)	PPARG
ABL2	CDKN2A	GFAP	MSLN (7E6A6)	PPM1A
ADAM10	CEA (1C7)	GSK3B	MSLN (5C11A4)	PR
AFP	CEA (3G12)	GSTM1 (1H4A4)	MSLN (4H12F8)	PSA (KLK3)
Akt2	CHK2	GSTM1 (1H4F2)	MSX1	PTEN
Akt3	C-Kit	GSTP1	MTHFR	PTK6
AIB1	CRTC1	HAS1	MUC16 (CA 125) (2E9C2)	PTK7
ALDH1A1 (2G1G4)	CSF1	HAS2	MUC16 (CA 125) (4C8C8)	RB
ALDH1A1 (5A11)	CSNK2A2	HAUSP	MUC2 (7B8G10)	RET (6E4C4)
ALDH1A1 (2B2G1)	CTCF	HDAC3 (3A7B5)	MUC2 (4A5G8)	RET (8D10C9)
AMACR	CTTN	HDAC3 (7G6C5)	MUC2 (2G4B7)	RPS6KB1
Androgen receptor	CYP1A1	HIF1A	MUC5AC (8H8G6)	RUNX3
ANPEP (1C7D7)	Cytokeratin(Pan) (7H8)	HK2	MUC5AC (7E9D8)	S100B
ATM	CK7 (keratin 7)	Anti-HLA-Class I (MEM-147)	MYC	SCGB2A2
AURKA (1F8, 4G10)	Cytokeratin 8	Anti-HLA-Class I (W6/32)	NACC1	SERPINE1
B2M (3G5H8)	KRT13 (keratin 13)	Anti-HLA-DR (L243)	NANOG	SIRT1
B2M (4G5A1	CK17 (keratin 17)	Anti-HLA-DR (MEM-12)	NBN (7E4A2)	SMAD4
BCL-2 (8E12)	Cytokeratin 18	Anti-HLA-DR (BRA30)	NBN (7E4C2)	SNAI1
BECN1	KRT20 (keratin 20)	IGF2	NCAM1 (1F6F10)	SNAI2 (2H5)
BIRC5	DDR1	IGF2BP3	NCAM1 (5G5G1)	SNAI2 (4B6D5)
BMI1	DKK3 (4G7)	IGFBP2	NFKB1 (5D10D11)	SNCG (breast cancer-spec. prot. 1)
BRAF (1H12)	DKK3 (8A5C6)	INHA (4A2)	NFKB1 (5D10)	SOX2 (10F10)
BRAF (1H12F1)	DLK1	INHA (4E2)	NGFR	SOX2 (10F10C9)
BRCA1	E2F1	ITGB1 (3B6)	NKX3A	SPP1
BRIP1 (1B8F9)	EGFR (7A6F12)	ITGB1 (3B6B2)	NME1	SRA (1D4H8)
BRIP1 (4C6C8)	EGFR (5E10D3)	ITK (5G12C4)	NOS2	SRA (7H1G1)
CA9	EGFR mutant	ITK (5G6)	NQO1 (1A11)	SRC (1F11)
CCNB1 (1B10, 5G6)	EGR1	JAK3	NQO1 (4D12)	SRC (4F1E8)
CCND1	eNOS	KI67 (4A1)	NT5E (4G6B10)	SRC (5D10C4)
CCND3	EP300	KI67 (9C12B2)	NT5E (4G6E3)	SST
CD9	E7 (3D6F1)	KI67 (8D5)	NT5E (1D7)	STAT3
CD14	E7 (6F3)	KIT	NTRK3 (4G5)	STAT5A
CD24	EpCAM	KLF4 (1E5)	NTRK3 (7H6)	STAT5B
CD31	EphA2	KLF4 (1E6)	Nucleophosmin	STK11
CD34 (4H5E7)	EphB4	KLK3	Oct4 (1D10H6)	Survivin
CD34 (581)	ERBB2 (HER-2) (6C2B12)	LAMB1	Oct4 (3A5)	SUZ12 (2C11)
CD39 (8E9F2)	ERBB2 (HER-2) (9B9D8)	Lck	Oct4 (5F7)	SUZ12 (3D10)
CD39 (6H12F9)	ERBB2 (HER-2) (6C2)	LGR5 (2B5C3)	Oct4 (7E7)	TGF beta1
CD44 (MEM-185)	ERBB3 (2B11D11)	LGR5 (2B5B9)	OLIG2	TGFb1 (7F6)
CD44 (8E2F3)	ERBB3 (2F9)	LPP	p16 (1E12E10)	THY1
CD80	ERBB3 (3F10F6)	Mammaglobin-1	p16 (2D9A12)	TNF-alpha
CD87	ERK2	MAP1LC3A	p16 (5A8A4)	TNNI2 (2F12A11)
CD105	ESR1 (10H12B10)	MAP2K4	p44/42 MAPK (Erk1/2)	TNNI2 (2F12A8)
CD133	ESR1 (2G112B3)	MAPK8	p53	TNNI2 (2F12G2)
CD147 (5A6F8)	ESR1 (6B6)	MATK	p53	TOP2A (6C12G12)
CD147 (2D8C11)	ESR1 (8H9A10)	MCM2 (1E7)	p63a	TOP2A (6D4B2)
CD147 (3E10C1)	ETS1 (10D2)	MCM2 (2B3)	PAR4	TrkA
CD147 (7H4D4)	ETS1 (8A8)	MELK	PARP	TTR (2E10C5)
CD147 (5A6F8)	FAK (10H7)	MER	PAX4	TTR (6F11B2)
CD148 (1D2C11)	FAK (10H7A6)	Metadherin	PAX8	TUBB3
CD148 (6F2E12)	FAK (10H7E9)	MLH1	PCNA	TWIST1 (10E4E6)
CD152	FAS (4F8H6)	MLL	PHB	TWIST1 (2F8E7)
CD171	FAS (4F8D6)	MMP2	PIK3CA	Tyk2
CD227 (CA 15-3)	FES 2E3G3	MMP3	Pirh2	UBE1L
CD276	FES (5A11G5)	MMP9 (5C3)	PLK1	Vimentin (4F2E9)
CDC2 (8C5A6)	FGFR4	MMP9 (5G3)	PMS2 (6G12E1)	Vimentin (9E7E7)
CDC2 (8C5A7F10)	FLT4	MSI1	PMS2 (5A7F2)	WIF1
CDH1 (7A2)	FOLR1 (3G12B7)	MSH2	PMS2 (8E4G11)	WNT10B
CDH1 (7H12)	FOLR1 (2G5C12)	MSH6 (3A10H7)	PMS2 (1E9D11)	XRCC5

back to main